Emcure Pharma Cuts Poviztra Price by 55%, Starting Dose Now Rs 3,999 per Month Parthika Patel4 April 2026 2:25 PM ISTNew Delhi: Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug...
USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk sheeba farhat3 April 2026 2:49 PM ISTWashington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...
USFDA Approves Higher-Dose Wegovy to Boost Weight Loss Outcomes sheeba farhat21 March 2026 11:00 AM ISTWashington: Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help users lose more...
Pfizer's GLP-1 Drug Xianweiying Wins China Approval for Long-Term Weight Management sheeba farhat8 March 2026 11:30 AM ISTShanghai: China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said...
Biocon Gets USFDA Nod for gSaxenda, Enters US GLP-1 Weight Loss Market sheeba farhat25 Feb 2026 2:55 PM ISTNew Delhi: Biocon Limited has secured approval from the U.S. Food and Drug Administration (USFDA) for its complex formulation Liraglutide Injection,...
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices Susmita Roy29 Jan 2026 11:15 PM ISTNew Delhi: India's Free Trade Agreement (FTA) with the European Union is being projected as a major breakthrough for healthcare, with expectations of...
Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal sheeba farhat21 Jan 2026 7:01 PM ISTMumbai: Global pharmaceutical major Lupin Limited on Tuesday announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings...
Novo Nordisk's Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment sheeba farhat17 Jan 2026 4:06 PM ISTThe authorisation for the drug, chemically known as semaglutide, covers only patients with a body mass index of 30 or higher using the drug for weight...
Cipla Emerges as Domestic Contender in Anti-Obesity Market with Yurpeak Susmita Roy10 Jan 2026 10:06 PM ISTNew Delhi: India's third-largest drugmaker Cipla has made an early impact in the fast-expanding anti-obesity drug market, with its GLP-1 agonist brand...
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India's Top-Selling Drug Farhat Nasim8 Nov 2025 5:06 PM ISTNew Delhi: Eli Lilly's diabetes and obesity drug Mounjaro (Tirzepatide) has become India's top-selling drug by value for October 2025, overtaking...
AACE Releases Adiposity-Based Chronic Disease (ABCD) 2025 Guidelines: Top Highlights from Consensus Statement Dr. Bhumika Maikhuri13 Oct 2025 12:45 PM ISTThe American Association of Clinical Endocrinology (AACE) has released its 2025 Consensus Statement, introducing a transformative approach to...
Medical Bulletin 15/Jul/2025 Dr. Bhumika Maikhuri15 July 2025 3:00 PM ISTHere are the top medical news for the day:Where, How, and Why You Exercise Affects Mental Health: StudyPublished in Medicine and Science in Sports and...
